Literature DB >> 15966981

Spread of novel expanded-spectrum beta-lactamases in Enterobacteriaceae in a university hospital in the Paris area, France.

M-F Lartigue1, N Fortineau, P Nordmann.   

Abstract

In 2002, 28 non-duplicate enterobacterial isolates producing extended-spectrum beta-lactamases (ESBLs) were collected from infected patients at the Bicêtre Hospital in Paris, France. Escherichia coli was the predominant ESBL-positive enterobacterial species, comprising ten (36%) of the isolates. CTX-M enzymes (CTX-M-3, CTX-M-10, CTX-M-14 and CTX-M-15) were produced by 11 (39%) of the isolates (six E. coli, two Enterobacter cloacae, one Enterobacter aerogenes, one Proteus mirabilis and one Citrobacter freundii). Other ESBLs, such as VEB-1 and PER-1, were also detected, but less frequently.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15966981     DOI: 10.1111/j.1469-0691.2005.01172.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  15 in total

1.  Pyrosequencing as a rapid tool for identification of GES-type extended-spectrum beta-lactamases.

Authors:  Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

2.  Extended-spectrum-beta-lactamase-producing Enterobacteriaceae strains in various types of private health care centers.

Authors:  Corinne Arpin; Laure Coulange; Véronique Dubois; Catherine André; Isabelle Fischer; Sophie Fourmaux; Frédéric Grobost; Jacqueline Jullin; Brigitte Dutilh; Jean-Francois Couture; Patrick Noury; Isabelle Lagrange; Aline Ducastaing; Henri-Pierre Doermann; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2007-06-25       Impact factor: 5.191

3.  Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.

Authors:  Marie-Frédérique Lartigue; Catherine Zinsius; Aline Wenger; Jacques Bille; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

4.  Prevalence of fecal carriage of acquired expanded-spectrum cephalosporin resistance in Enterobacteriaceae strains from cattle in France.

Authors:  Jean-Yves Madec; Corinne Lazizzera; Pierre Châtre; Danièle Meunier; Sylvie Martin; Gérard Lepage; Marie-Françoise Ménard; Patricia Lebreton; Thomas Rambaud
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

5.  CTX-M-type extended-spectrum beta-lactamases in Italy: molecular epidemiology of an emerging countrywide problem.

Authors:  Claudia Mugnaioli; Francesco Luzzaro; Filomena De Luca; Gioconda Brigante; Mariagrazia Perilli; Gianfranco Amicosante; Stefania Stefani; Antonio Toniolo; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

6.  Evaluation of a DNA microarray, the check-points ESBL/KPC array, for rapid detection of TEM, SHV, and CTX-M extended-spectrum beta-lactamases and KPC carbapenemases.

Authors:  T Naas; G Cuzon; H Truong; S Bernabeu; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

7.  Molecular identification of extended-spectrum-β-lactamase genes from Enterobacteriaceae isolated from healthy human carriers in Switzerland.

Authors:  Nadine Geser; Roger Stephan; Bozena M Korczak; Lothar Beutin; Herbert Hächler
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

8.  Identification of CTX-M-type extended-spectrum-beta-lactamase genes using real-time PCR and pyrosequencing.

Authors:  Thierry Naas; Cynthia Oxacelay; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2006-11-06       Impact factor: 5.191

Review 9.  The continuing challenge of ESBLs.

Authors:  Federico Perez; Andrea Endimiani; Kristine M Hujer; Robert A Bonomo
Journal:  Curr Opin Pharmacol       Date:  2007-09-17       Impact factor: 5.547

10.  Ertapenem resistance of Escherichia coli.

Authors:  Marie-Frédérique Lartigue; Laurent Poirel; Claire Poyart; Hélène Réglier-Poupet; Patrice Nordmann
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.